A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease
Phase 1 study testing an investigational treatment in Huntington's disease.
RecruitingPhase 1DrugClinicalTrials.govTreatment trial
Recruiting in: Berlin, Birmingham, Bochum +16 more (Canada, Germany, United Kingdom)
Sponsor: Alnylam Pharmaceuticals
Preparing a short plain-English summary.